N8-GP (Turoctocog alfa pegol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for N8-GP (Turoctocog alfa pegol), covering 2024-01-18 to 2024-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10) [Phase 3]